Nov 07, 2019 / 10:00PM GMT
Operator
Greetings, and welcome to the Navidea's Biopharmaceuticals Third Quarter 2019 Earnings Call. (Operator Instructions) I will now turn the conference over to your host, Jed Latkin, you may begin, Mr. Latkin.
Jed A. Latkin - Navidea Biopharmaceuticals, Inc. - CEO, COO, CFO & Director
Thank you, Jerry. Good afternoon, and welcome, everyone, to Navidea's Third Quarter 2019 Earnings Call. I am Jed Latkin, Chief Executive Officer of Navidea Biopharmaceuticals. This call will cover Navidea's financial operating results for the third quarter of 2019, which ended on September 30, 2019, along with a discussion of goals and milestones for the remainder of 2019 and into 2020. Following our prepared remarks, we will open up the conference call to a question-and-answer session.
With me on our call today is our Chief Medical Officer, Dr. Mike Rosol; and our Director of Finance and Administration, Erika Gibson. But before we begin our formal remarks, I would like to remind everyone that some of the statements on this conference call may be considered forward-looking
Q3 2019 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers